ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Drug developer BenevolentAI enters SPAC merger deal with Odyssey
December 08, 2021UK-based clinical-stage artificial intelligence (AI) drug discovery firm BenevolentAI has signed a definitive agreement for a business combination with the special-purpose acquisition company (SPAC) Odyssey Acquisition. -
EQRx signs $1.8bn merger deal with CM Life Sciences III
August 10, 2021Pharmaceutical company EQRx and a life science-focused special purpose acquisition company (SPAC), CM Life Sciences III, have signed a definitive business combination agreement worth up to $1.8bn. -
Humacyte agrees SPAC merger to go public with bioengineered tissue tech
February 23, 2021Human tissue bioengineering biotech Humacyte has entered into a business combination agreement with special purpose acquisition company (SPAC) Alpha Healthcare Acquisition Corp (AHAC).
Pharma Sources Insight January 2025
